Prophylactic, single-drug cardioprotection in a comparative, experimental study of doxorubicin-induced cardiomyopathy.

J Transl Med · 2020 · PMC7725221 · PMID 33298102

Europe PMC DOI

hedged sentence

0.0633

closest p · 1.3× alpha

0.0633

boldest claim

The sentences

did not reach statistical significancep = 0.0633so close (0.05 < p ≤ 0.1)

FoxO1 levels appeared to be lower in the D-CON group compared to CON, however, this change did not reach statistical significance (0.17 ± 0.03 vs. 0.29 ± 0.05 AU in D-CON and CON, respectively, p = 0.0633) (Fig. 6 b).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.